art

Hyundai Motor Group Announces Grand Prix Recipient and Exhibitions of the 6th VH AWARD

Hyundai Motor Group premieres five commissioned artworks of the 6th VH AWARD screening at HEK (House of Electronic Arts) during…

8 months ago

“AI and the Art Market” by Arte, with Artprice by Artmarket and analysis by Perplexity.AI Labs

PARIS, June 16, 2025 /PRNewswire/ -- This Sunday, June 15th, 2025, the Franco-German TV channel Arte broadcast the documentary "AI…

8 months ago

XPPen Partners with Annecy International Animation Film Festival to Launch the Inaugural XPPen Award for Graduation Films, Nurturing the Next-Gen Talent

LOS ANGELES, June 16, 2025 /PRNewswire/ -- XPPen, the leading digital art innovation brand, is thrilled to announce its partnership…

8 months ago

Pioneering Sustainable Solutions: The Art of Living’s 4R Approach

BENGALURU, India, June 13, 2025 /PRNewswire/ -- Water, the elixir of life, is under severe threat worldwide, and India is…

8 months ago

Dazu Rock Carvings: The Last Monument of World Grotto Art

CHONGQING, China, June 12, 2025 /PRNewswire/ -- Located in southwest China's Chongqing Municipality, the Dazu Rock Carvings have held UNESCO…

8 months ago

Metamorphoses | 2025 CAA Graduation Season

HANGZHOU, China, June 10, 2025 /PRNewswire/ -- As 2025 approaches its most vibrant and life-affirming season, the China Academy of…

8 months ago

AUTOMOBILI PININFARINA UNVEILS ONE-OF-A-KIND BATTISTA NOVANTACINQUE TO CELEBRATE 95 YEARS OF ICONIC DESIGN

Automobili Pininfarina has unveiled the Battista Novantacinque, a bespoke model created as a tribute to the 95th anniversary of Pininfarina…

9 months ago

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant…

9 months ago

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first…

9 months ago